Read the latest news around Y2X Life Sciences and our vision to change the way the world thinks about disinfection and disease transmission. We develop innovative products and technologies that make the greatest global impact across economic and cultural borders. And, our team of bioscientists are ambitious and dedicated in the pursuit to leverage technology that saves lives, ensures safe environments, and prevents future pandemics.
Y2X Life Sciences’ Academic Partners at Washington University in St. Louis Received $3.6 Million Dollar Grant
Y2X Life Sciences' academic partners at Washington University in St. Louis received a $3.6 million grant from FluLab to advance R&D on the breathalyzer test. This non-dilutive grant will expedite commercialization of the breathalyzer and enable development of the nanobody…